Le Lézard
Classified in: Health
Subjects: PDT, WOM

InventHelp Inventor Develops New Female Incontinence Product (CHK-972)


PITTSBURGH, Jan. 24, 2024 /PRNewswire/ -- "I am a CNA with frequent urinary infections of my own. I wanted to protect myself from accidentally spreading or splashing feces onto my genital area," said an inventor from Round Lake, IL, "so I invented the Fanny Shield. My design can reduce the potential for toilet water or paper to spread feces to the female genitalia area. Which will, in turn, reduce the risk of urinary tract infections."

The patent-pending Fanny Shield is a barrier protection product that would allow women to have a bowel movement without the risk of a urinary tract infection. This simple, convenient design can be used by bedridden or mobile women, as it will be offered in two different designs. Women could use one design on the go, and bedridden individuals can use the other. This product will increase sanitary conditions and provide women with protection and peace of mind.

The original design was submitted to the Chicago sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dep22-CHK-972, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 15:25
UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Celebrate Women's Heart Health Month With Gundry MD Energy Renew
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch and C-RAD sign collaboration agreement
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
Second Opinion Expert Announces OC FERTILITY® + OC BIOGENIX® To Join Its Panel To Provide Expert Second Opinions.
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Robert Galibert Makes a Drug-Free French Connection on Voices for Humanity
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....

More news about Health...


News published on and distributed by: